Application of ultra-low-amount contrast agent in coronary artery imaging of renal insufficiency patient
A coronary and contrast agent technology, which is applied in the application field of ultra-low contrast agent in coronary imaging of patients with renal insufficiency, can solve problems such as contrast agent nephropathy, achieve definite diagnosis and treatment, and reduce the effect of impact
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0019] Sequential selection of 107 inpatients who underwent coronary artery CTA examination in the CT room of Liaocheng People's Hospital from 2017.02.01 to 2017.10.01. The patients were required to be younger than 75 years old, blood pressure 90 / 60mmHg-140 / 90mmHg, BMI value 18-26, heart rate <60 times / min, 14 patients with renal insufficiency were included in the selected patients.
[0020] According to the heart rate, 18ml of contrast agent iopamidol 370 was used to scan and image the coronary artery with CTA. The contrast agent staining of the right atrium was observed with the naked eye, and the scan was performed according to the concentration of contrast agent staining and heart rate. The scanning time is 0.3-0.8s.
[0021] Coronary artery scan was performed with 18ml contrast dose, and the results were as follows: figure 1 as shown, figure 1 Middle, A: ascending aorta CT value 311.2HU; B: left coronary artery (LAD) CT value 292.1HU; C: right coronary artery (RCA) CT v...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com